Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
Gl0034 Dose Level 1, Gl0034 Dose Level 2, Gl0034 Dose Level 3, Gl0034 Dose Level 4, Gl0034 Dose Level 5, Gl0034 Dose Level 6
Type Ii Diabetes Mellitus
Phase II
Recruiting
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Dec 05, 2025
―
Vehicle, Reformulated Levulan Kerastick Containing Aminolevulinic Acid Hydrochloride, 20%, Blue Light Photodynamic Therapy Illuminator Device, Blu-U Model 4170E.
Actinic Keratosis
Phase III
Not Yet Recruiting
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Aug 20, 2025
Reformulated Levulan Kerastick Containing Aminolevulinic Acid Hydrochloride, 20%, Vehicle Containing Excipients Only Without Active Ingredient, Blue Light Photodynamic Therapy Illuminator Device, Blu-U Model 4170E.
Actinic Keratosis
Phase III
Not Yet Recruiting
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Aug 20, 2025
Trifarotene Cream 0.005%, Aklief Cream Us Reference Listed Drug, Aklief Cream Canadian Reference Product
Acne Vulgaris
Phase I
Completed
A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris
Dec 10, 2024
―
Ruxolitinib Topical Cream 1.5%, Opzelura Cream
Atopic Dermatitis
Phase I
Completed
A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.
Nov 02, 2024
―
Clindamycin Phosphate, Adapalene, And Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2%, Cabtreo Topical Gel
Acne Vulgaris
Phase I
Completed
A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.
Nov 02, 2024
―
Tildrakizumab 100 Mg
Moderate To Severe Genital Psoriasis
Phase III
Active Not Recruiting
A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.
Sep 23, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sun Pharmaceutical Industries Limited (SUNPHARMA) have in its pipeline
SUNPHARMA is currently developing the following drugs: Gl0034, Gl0034 Dose Level 1, Gl0034 Dose Level 2, Gl0034 Dose Level 3, Gl0034 Dose Level 4, Gl0034 Dose Level 5, Gl0034 Dose Level 6, Vehicle, Reformulated Levulan Kerastick Containing Aminolevulinic Acid Hydrochloride, 20%, Blue Light Photodynamic Therapy Illuminator Device, Blu-U Model 4170E.. These drug candidates are in various stages of clinical development as the company works toward FDA approval.